trending Market Intelligence /marketintelligence/en/news-insights/trending/tU46YCoRW00T-l9ZGeEhrg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Spring Bank Pharmaceuticals replaces chairman; director steps down

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Spring Bank Pharmaceuticals replaces chairman; director steps down

Spring Bank Pharmaceuticals Inc. named Scott Smith to be the company's chairman, effective Jan. 1, 2019.

Smith will replace Martin Driscoll, who will continue as the company's president and CEO.

Meanwhile, Christiana Bardon stepped down as a director of the U.S.-based clinical-stage biopharmaceutical company.